Cosette Pharmaceuticals Acquires Vyleesi from Palatin Technologies
January 3, 2024
Cosette Pharmaceuticals, a U.S. specialty pharmaceutical company backed by Avista Healthcare Partners, has acquired the Vyleesi (bremelanotide) product and related intellectual property from Palatin Technologies. The deal transfers five Orange Book-listed patents (protection through 2041) and aims to expand Cosette’s women's health portfolio while ensuring continued patient access during the transition.
- Buyers
- Cosette Pharmaceuticals, Inc., Avista Healthcare Partners
- Targets
- Vyleesi (bremelanotide injection)
- Sellers
- Palatin Technologies, Inc.
- Industry
- Pharmaceuticals
- Location
- New Jersey, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.